ATE193726T1 - Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung - Google Patents

Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Info

Publication number
ATE193726T1
ATE193726T1 AT92302004T AT92302004T ATE193726T1 AT E193726 T1 ATE193726 T1 AT E193726T1 AT 92302004 T AT92302004 T AT 92302004T AT 92302004 T AT92302004 T AT 92302004T AT E193726 T1 ATE193726 T1 AT E193726T1
Authority
AT
Austria
Prior art keywords
nucleotide sequence
specific nucleotide
containing specific
strain containing
measles virus
Prior art date
Application number
AT92302004T
Other languages
English (en)
Inventor
Keiko Sasaki
Takayuki Mori
Satoshi Makino
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE193726T1 publication Critical patent/ATE193726T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92302004T 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung ATE193726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3293625A JP3045581B2 (ja) 1991-10-14 1991-10-14 麻疹ワクチンウイルス株同定方法

Publications (1)

Publication Number Publication Date
ATE193726T1 true ATE193726T1 (de) 2000-06-15

Family

ID=17797135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302004T ATE193726T1 (de) 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Country Status (10)

Country Link
US (2) US5654136A (de)
EP (1) EP0540135B1 (de)
JP (1) JP3045581B2 (de)
KR (1) KR950012759B1 (de)
AT (1) ATE193726T1 (de)
DE (1) DE69231143T2 (de)
DK (1) DK0540135T3 (de)
ES (1) ES2148164T3 (de)
GR (1) GR3034278T3 (de)
PT (1) PT540135E (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07509122A (ja) * 1992-04-08 1995-10-12 ザ　ガバメント　オブ　ザ　ユナイテッド　ステイツ　オブ　アメリカ，アズ　レプリゼンテッド　バイ　ザ　セクレター，デパートメント　オブ　ヘルス　アンド　ヒューマン　サービシーズ 野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法
US6638482B1 (en) * 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
ATE226594T1 (de) * 1996-07-31 2002-11-15 Claude P Muller Peptide abgeleitet aus dem morbillivirus
KR20000048628A (ko) * 1996-09-27 2000-07-25 윌리암 에이취 캘넌, 에곤 이 버그 모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이
JP4043054B2 (ja) * 1997-06-04 2008-02-06 財団法人阪大微生物病研究会 変異麻疹ウイルス抗原及びそれをコードする遺伝子
EP1064358A2 (de) * 1998-03-26 2001-01-03 American Cyanamid Company Mutationen die für abschwächung von masern-virus oder von menschlichen respiratorischen synzytialvirus verantwortlich sind
AU781005B2 (en) * 1999-11-19 2005-04-28 Daiichi Sankyo Company, Limited Method for producing cell-fusion type morbillivirus mutant
JP3946045B2 (ja) * 2000-01-31 2007-07-18 財団法人阪大微生物病研究会 弱毒生水痘ワクチンの品質管理方法
CA2399504C (en) * 2000-02-10 2011-02-22 The Kitasato Institute Methods for producing temperature-sensitive morbillivirus
DK1375670T3 (da) 2002-06-20 2013-09-23 Pasteur Institut Rekombinante mæslingevira, der udtrykker epitoper af RNA-viras antigener, samt anvendelse af de rekombinante vira til fremstilling af vaccinesammensætninger
DK1375512T3 (da) * 2002-06-20 2009-10-26 Pasteur Institut Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP2420242A1 (de) 2010-08-20 2012-02-22 Lauer, Ulrich M. Onkolytisches Masernvirus
CN104211769B (zh) * 2013-05-30 2018-08-03 中国科学院过程工程研究所 一种小分子抗体亲和肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
US5824777A (en) 1998-10-20
ES2148164T3 (es) 2000-10-16
EP0540135A2 (de) 1993-05-05
KR950012759B1 (ko) 1995-10-21
DE69231143T2 (de) 2000-10-19
DE69231143D1 (de) 2000-07-13
PT540135E (pt) 2000-11-30
KR930008138A (ko) 1993-05-21
US5654136A (en) 1997-08-05
EP0540135B1 (de) 2000-06-07
EP0540135A3 (en) 1993-12-08
JPH05103665A (ja) 1993-04-27
GR3034278T3 (en) 2000-12-29
DK0540135T3 (da) 2000-08-07
JP3045581B2 (ja) 2000-05-29

Similar Documents

Publication Publication Date Title
DE69231143D1 (de) Spezifische Nukleotidsequenz enthaltender Masernvirusvakzinstamm und Verfahren zu seiner absoluten Identifizierung
ATE238434T1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
DE69122712D1 (de) Verfahren zur nukleinsäure hybridisierung und amplifizierung
DE3888425D1 (de) Virale Expressionsinhibitoren.
ATE353973T1 (de) Die verwendung der 3'-wesentlichen bearbeitungswirksamkeit von dns-polymerase
DE69329636D1 (de) Verfahren zur Vervielfältigung von Nukleinsäuresequenzen
FI930658A0 (fi) Oligonukleotider foer modulering av effekten av cytomegalovirusinfektioner
FI893526A7 (fi) Välineitä ja menetelmä nukleiinihappohybridisaation lisäämiseksi
EP0754765A3 (de) DNS Sequenzierung und DNS Kettenabbrecher
ZA925259B (en) Immobilization of nucleic acids
EP0438292A3 (en) Method of preparing primers for polymerase chain reaction and dna amplification using said primers
CA2066998A1 (en) Recombinant varicella-zoster virus and process for constructing same
NO940658L (no) Nukleinsyre-polymerase-forökning
DK0527941T3 (da) Identifikation af hidtil ukendte lægemidler og reagenser
DE69225050D1 (de) Uricase kodierende DNA und Verfahren zur Herstellung von Uricase
FI920636A7 (fi) DNA-koettimia ja alukkeita B. burgdorferin havaitsemiseksi polymeraasi ketjureaktiota käyttäen
DE68913128D1 (de) Verfahren zur Herstellung von L-Alanin-Dehydrogenase und Mikroorganismusstamm des Genus Sporolactobacillus.
DE3887710D1 (de) 1-(3,5-Di-0-benzoyl-2-deoxy-beta-D-threo-pentofuranosyl)Thymine und Verfahren zu deren Herstellung.
DK727688A (da) Malariaspecifikke dna-sekvenser, deres expressionsprodukter samt anvendelsen heraf
DE69230345D1 (de) Nachweis von einem genort
ATE108834T1 (de) Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke.
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
NO875058L (no) Oligonukleotidprober og fremgangsmÿte for detektering av nukleinsyrene i bakterier og andre levende organismer ved hybridisering.
LV10311B (en) Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification